A Study to Evaluate the Efficacy and Safety of TL118 in Solid Tumors Patients
NCT06010342
·
clinicaltrials.gov ↗
PHASE2
Phase
RECRUITING
Status
60
Enrollment
INDUSTRY
Sponsor class
Conditions
Solid Tumor
Interventions
DRUG:
TL118 Capsule
Sponsor
Teligene US